2019 ABSTRACT SUBMISSION DATES
General Abstract Submission:
November 12, 2018 – January 14, 2019 (11:00am EST)
NOTIFICATIONS WILL BE SENT BY: APRIL 1ST*
Latebreaker Abstract Submission*:
February 4, 2019 – March 4, 2019 (11:00am EST)
NOTIFICATIONS WILL BE SENT BY: MAY 1ST*
*If you have not received notification by the dates listed above, please contact Courtney Long (firstname.lastname@example.org).
Updated Abstract Submission Policy:
The SER Executive Committee has provided further policy details relating to qualifications for submitting a late-breaking abstract. Please review the policy below for eligibility requirements.
Interested in learning how the Society selects abstracts for inclusion in the annual meeting? Click here to review SER Processes.
Abstract Submission Policy
Abstracts derived from papers already published, either in print or in an online format, are not eligible for consideration to present at SER. Papers accepted but not yet published may be submitted, but in the event that the paper is published in advance of the SER meeting, the abstract will be withdrawn from presentation.
Please use the following guidance to prepare your abstract for online submission:
All abstracts must be submitted, in English, online. Use sentence case for your title.
Do not include references, tables, or mathematical equations in the abstract. Avoid acronyms and, where necessary, spell them out when used for the first time (ORs, RRs and CIs do not need to be spelled out). Select one topic area from the list below, which will be used to organize concurrent contributed sessions. The abstract should not exceed 2,000 characters, INCLUDING spaces. Author information is in addition to the 2,000 characters.
New this year, SER will allow one figure upload, with the abstract submission. Figure must be saved in .jpg format and uploaded at the time of submission.
Presentation of specific data and methodologic details assist reviewers in judging the quality of the research and are weighed more favorably than affirmation of known relations. Clarity and brevity of writing will allow evaluation of the importance of the research. Each abstract is scored by two reviewers. An overall acceptance proportion is applied to each subject area. The allocation of papers therefore represents the number of abstracts submitted for the subject areas.
For the general submission the submitting author will be notified by email on or before April 1, 2019 with a final decision. Notifications for Latebreaker abstracts will be sent on or before May 1, 2019. If you do not receive a notification, please contact Ms. Courtney Long (email@example.com) after these date.
Late Breaking Abstract Policy
What is the difference between the General Abstract Submission and Late Breaking Abstract Submission?
1. The General Abstract Submission and Late Breaking Abstracts run on a different submission schedule.
2. All submission categories remain the same fro the General Abstract Submission and Late Breaking Abstract Submission
3. A higher percentage of abstracts are accepted through the General Abstract Submission.
4. Late Breaking Abstract Submissions will now require a short summary as to how the abstract qualifies as ‘late breaking’.
What is considered ‘late breaking’?
Generally, “late breaking” abstracts are those which are (i) of high relative urgency for dissemination (substantively or methodologically), and which (ii) for compelling reasons could not have been submitted under the regular deadline. Compelling reasons might include data becoming available for analysis soon before the regular due date; “I forgot to finish my abstract on time” is unlikely to pass muster. Truly late breaking results which are not of high importance are less likely to receive serious consideration.
2019 Abstract Categories
HIV / STI
Perinatal & Pediatric
Translational & Implementation Science
We encourage abstracts representing all areas of research.
This year, we especially encourage submissions (with no guarantee of acceptance) in the following key public health areas: gun violence, opioids, suicide, mental health, cardiovascular diseases, translational research and clinical epidemiology.